These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9403377)

  • 21. Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents.
    Zavadenko NN; Guzilova LS
    Neurosci Behav Physiol; 2009 May; 39(4):323-8. PubMed ID: 19340573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piracetam treatment in patients with cognitive impairment.
    Rao MG; Holla B; Varambally S; Raveendranathan D; Venkatasubramanian G; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(4):451.e5-6. PubMed ID: 22763000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimyoclonic efficacy of piracetam in idiopathic generalized epilepsy.
    Khani YA; Andermann F; Andermann E
    Epilepsia; 2005 Jul; 46(7):1145-6. PubMed ID: 16026569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of piracetam on urea-induced myoclonus in rats].
    Nanri M; Yamamoto A; Matsuura N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):45-50. PubMed ID: 11062861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of cerebrolysin on cognitive functions in childhood autism and in Asperger syndrome].
    Krasnoperova MG; Bashina VM; Skvortsov IA; Simashkova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(6):15-8. PubMed ID: 12872620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levetiracetam in autistic children: an open-label study.
    Rugino TA; Samsock TC
    J Dev Behav Pediatr; 2002 Aug; 23(4):225-30. PubMed ID: 12177568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two cases of cluster headache effectively treated with levetiracetam.
    Palermo A; Giglia G; Cosentino G; Raieli V; Brighina F; Fierro B
    Funct Neurol; 2013; 28(1):63-4. PubMed ID: 23731917
    [No Abstract]   [Full Text] [Related]  

  • 28. [Application of nootropic agents in complex treatment of patients with concussion of the brain].
    Tkachev AV
    Lik Sprava; 2007; (5-6):82-5. PubMed ID: 18418926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the reaction to damage to the case in caddisfly larvae under the influence of piracetam].
    Inozemtsev AN; Nepomniashchikh VA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1995; 45(6):1211-3. PubMed ID: 8585313
    [No Abstract]   [Full Text] [Related]  

  • 30. [The results of using lucetam in patients with moderate cognitive impairment of different genesis].
    Batysheva TT; Otcheskaia OV; Nesterova ON; Lisinker LN; Bobina LA; Ismailov AM; Shekkhirimov RK; Zhuravleva EIu; Kamchatnov PR; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):63-5. PubMed ID: 19255983
    [No Abstract]   [Full Text] [Related]  

  • 31. [Individual sensitivity of Wistar rats to piracetam].
    Nikol'skaia KA; Kondrashevskaia MV; Eremina LV
    Ross Fiziol Zh Im I M Sechenova; 2007 Nov; 93(11):1308-18. PubMed ID: 18198598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Participation of GABA--benzodiazepine receptor complex in the anxiolytic effect of piracetam].
    Moldavkin GM; Voronina TA; Neznamov GG; Maletova OK; Eliava NV
    Eksp Klin Farmakol; 2006; 69(3):7-9. PubMed ID: 16878489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of piracetam on the conditional reflex memory under probable reinforcement conditions].
    Riabchikova NA; Tushmalova NA; Pragina LL; Shul'govskiĭ VV
    Eksp Klin Farmakol; 2001; 64(6):17-9. PubMed ID: 11871229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ["Fast" and "slow" components of psychotropic activity of the drugs with nootropic effects].
    Neznamov GG; Siuniakov SA; Davydova IA; Teleshova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(6):33-7. PubMed ID: 10900686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
    Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
    Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced psychosis after long-term treatment with levetiracetam.
    Bayerlein K; Frieling H; Beyer B; Kornhuber J; Bleich S
    Can J Psychiatry; 2004 Dec; 49(12):868. PubMed ID: 15679219
    [No Abstract]   [Full Text] [Related]  

  • 37. Levetiracetam for agitated Alzheimer's disease patients.
    Weiner MF; Womack KB; Martin-Cook K; Svetlik DA; Hynan LS
    Int Psychogeriatr; 2005 Jun; 17(2):327-8. PubMed ID: 16050441
    [No Abstract]   [Full Text] [Related]  

  • 38. Piracetam for Sialorrhea in 2 Children With Intellectual Disability.
    Bozkurt H
    J Clin Psychopharmacol; 2015 Oct; 35(5):621-2. PubMed ID: 26252441
    [No Abstract]   [Full Text] [Related]  

  • 39. Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs.
    Gualtieri F; Manetti D; Romanelli MN; Ghelardini C
    Curr Pharm Des; 2002; 8(2):125-38. PubMed ID: 11812254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Novel endogenous dipeptide cycloprolyl-glycine is similar to pyracetam in selectivity of their mnemotropic effect].
    Gudasheva TA; Ostrovskaia RU; Trofimov SS; Voronina TA; Skoldinov AP; Seredenin SB
    Biull Eksp Biol Med; 1999 Oct; 128(10):411-3. PubMed ID: 10599497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.